Prevalence of cholesteryl ester storage disease [2]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 8, 2007, Pages 1866-1868

  Muntoni, Sandro ^a,b,e   Wiebusch, Heiko ^c   Jansen Rust, Marianne ^b   Rust, Stephan ^b   Seedorf, Udo ^b   Schulte, Helmut ^b   Berger, Klaus ^b   Funke, Harald ^d   Assmann, Gerd ^b,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e Sezione di Oncologia e Patologia Molecolare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER STORAGE DISEASE; DNA SCREENING; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEPATOMEGALY; HETEROZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LETTER; LIPID STORAGE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; TANGIER DISEASE; ULTRAVIOLET RADIATION; WOLMAN DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GERMANY; LIVER DISEASE; MALE; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT;

BASE SEQUENCE; CHOLESTEROL ESTER STORAGE DISEASE; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERMANY; HUMANS; LIVER DISEASES; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 34547636291     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.146639     Document Type: Letter

References (26)

1. Assmann G, Seedorf U. Acid lipase deficiency: Wolman disease and cholesterol ester storage disease. Sciver CR, Beuadet LA, Sly WS, Valle D. The Metabolic & Molecular Bases of Inherited Disease (8th edition) 2001;3551-3572. New York, McGraw-Hill.
2. Patrick AD, Lake BD. Deficiency of an acid lipase in Wolman's disease. Nature. 1969;222:1067-1068.
3. Seedorf U, Wiebusch H, Muntoni Sa, Christensen NC, Skovby F, Nickel V, Roskos M, Funke H, Ose L, Assmann G. A novel variant of lysosomal acid lipase (Leu336->Pro) associated with acid lipase deficiency and cholesterol ester storage disease. Arterioscler Thromb Vasc Biol. 1995;15:773-778.
4. Aslanidis C, Ries S, Fehringer P, Buchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics. 1996;33:85-93.
5. Du H, Sheriff S, Bezerra J, Leonova T, Grabowski GA, Sheriff S, Du H, Grabowski GA. Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease. Review. Mol Genet Metab. 1998;64:126-134.
6. vom Dahl S, Harzer K, Rolfs A, Albrecht B, Niederau C, Vogt C, van Weely S, Aerts J, Muller G, Haussinger D. Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation. J Hepatol. 1999;31:741-746.
7. Anderson RA, Bryson GM, Parks JS. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. Mol Genet Metab. 1999;68:333-345.
8. Elleder M, Chlumska A, Hyanek J, Poupetova H, Ledvinova J, Maas S, Lohse P. Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol. 2000;32:528-534.
9. Drebber U, Andersen M, Kasper HU, Lohse P, Stolte M, Dienes HP. Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report. World J Gastroenterol. 2005;11:2364-2366.
10. Pagani F, Pariyarath R, Garcia R, Stuani C, Burlina AB, Ruotolo G, Rabusin M, Baralle FE. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J Lipid Res. 1998;39:1382-1388.
11. Muntoni S, Wiebusch H, Funke H, Ros E, Seedorf, Assmann G. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet. 1995;95:491-494.
12. Pagani F, Garcia R, Pariyarath R, Stuani C, Gridelli B, Paone G, Baralle FE. Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease. Hum Mol Genet. 1996;5:1611-1617.
13. Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest. 1993;92:2713-2718.
14. Gasche C, Aslanidis C, Kain R, Exner M, Helbich T, Dejaco C, Schmitz G, Ferenci P. A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol. 1997;27:744-750.
15. Redonnet-Vernhet I, Chatelut M, Salvayre R, Levade T. A novel lysosomal acid lipase gene mutation in a patient with cholesteryl ester storage disease. Hum Mutat. 1998;11:335-336.
16. Redonnet-Vernhet I, Chatelut M, Basile JP, Salvayre R, Levade T. Cholesteryl ester storage disease: relationship between molecular defects and in situ activity of lysosomal acid lipase. Biochem Mol Med. 1997;62:42-49.
17. Ameis D, Brockmann G, Knoblich R, Merkel M, Ostlund RE Jr, Yang JW, Coates PM, Cortner JA, Feinman SV, Greten H. A 5′ splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease. J Lipid Res. 1995;36:241-250.
18. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: The MEMO Study. Neurology. 2000;54:1064-1068.
19. Rust S, Funke H, Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res. 1993;21:3623-3629.
20. Muntoni S, Wiebusch H, Funke H, Seedorf U, Roskos M, Shulte H, Saku K, Arakawa K, Balestrieri A, Assmann G. A missense mutation (Thr-6Pro) in the lysosomal acid lipase (LAL) gene is present with a high frequency in three different ethnic populations: impact on serum lipoprotein concentrations. Hum Genet. 1996;97:265-267.
21. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. J Am Med Assoc. 1999;281:249-254.
22. Lohse P, Maas S, Lohse P, Elleder M, Kirk JM, Besley Guy TN, Seidel D. Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease. J Lipid Res. 2000;41:23-31.
23. Levy R, Ostlund RE Jr, Schonfeld G, Wong P, and Semenkovich CF. Cholesteryl ester storage disease: complex molecular effects of chronic lovastatin therapy. J Lipid Res. 1992;33:1005-1015.
24. Rassoul F, Richter V, Lohse P, Naumann A, Purschwitz K, Keller E. Long- term administration of the 3hydroxy3methylglutaryl (HMG)-coenzymeA (CoA) reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease. Int J Clin Pharmacol Ther. 2001;39(5):199-204.
25. Tadiboyina VT, Liu DM, Miskie BA, Wang J, Hegele RA. Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease. Lipids Health Dis. 2005;4:26.
26. Hong D, Heur M, Witte D, Ameis D, Grabowski GA. Lysosomal acid lipase deficiency: Correction of lipid storage by adenovirus-mediated gene transfer in mice. Hum Gene Ther. 2002;13:11:1361-1372.